“…Despite recent exciting developments, it is only the beginning for complex tissue formation and disease modeling using hPSCs (Passier et al, 2016). There are still several challenges to be solved for hPSC-derived organoids: (1) the majority, if not all, of organoids differentiated from hPSC contain a mixture of other unwanted cell types that can potentially interfere with the interpretation of downstream assays; (2) hPSC differentiation mostly generates fetal cell types (Hrvatin et al, 2014;van den Berg et al, 2015), which also seems to be the case for hPSC-derived organoids (Dye et al, 2015;Finkbeiner et al, 2015;Takasato et al, 2015); and (3) the key to success of generation of organoids from hPSCs is the understanding of the successive signaling pathways controlling the whole differentiation process, the knowledge of which is primarily derived from animal studies and, in some cases, are not directly applicable for hPSC differentiation.…”